DE2537071A1 - Amid - Google Patents

Amid

Info

Publication number
DE2537071A1
DE2537071A1 DE19752537071 DE2537071A DE2537071A1 DE 2537071 A1 DE2537071 A1 DE 2537071A1 DE 19752537071 DE19752537071 DE 19752537071 DE 2537071 A DE2537071 A DE 2537071A DE 2537071 A1 DE2537071 A1 DE 2537071A1
Authority
DE
Germany
Prior art keywords
pro
formula
residue
pglu
vacuo
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
DE19752537071
Other languages
German (de)
English (en)
Inventor
Dieter Dr Gillessen
Rolf Dr Studer
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
F Hoffmann La Roche AG
Original Assignee
F Hoffmann La Roche AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by F Hoffmann La Roche AG filed Critical F Hoffmann La Roche AG
Publication of DE2537071A1 publication Critical patent/DE2537071A1/de
Pending legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/02Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
    • C07K5/0202Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -NH-X-X-C(=0)-, X being an optionally substituted carbon atom or a heteroatom, e.g. beta-amino acids
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06Dipeptides
    • C07K5/06139Dipeptides with the first amino acid being heterocyclic
    • C07K5/06147Dipeptides with the first amino acid being heterocyclic and His-amino acid; Derivatives thereof

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DE19752537071 1974-08-28 1975-08-20 Amid Pending DE2537071A1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH1172574 1974-08-28

Publications (1)

Publication Number Publication Date
DE2537071A1 true DE2537071A1 (de) 1976-03-18

Family

ID=4376294

Family Applications (1)

Application Number Title Priority Date Filing Date
DE19752537071 Pending DE2537071A1 (de) 1974-08-28 1975-08-20 Amid

Country Status (16)

Country Link
JP (1) JPS5148662A (US08066781-20111129-C00013.png)
AU (1) AU8356775A (US08066781-20111129-C00013.png)
BE (1) BE832783A (US08066781-20111129-C00013.png)
DD (1) DD123314A5 (US08066781-20111129-C00013.png)
DE (1) DE2537071A1 (US08066781-20111129-C00013.png)
DK (1) DK386275A (US08066781-20111129-C00013.png)
FI (1) FI752409A (US08066781-20111129-C00013.png)
FR (1) FR2282907A1 (US08066781-20111129-C00013.png)
GB (1) GB1478553A (US08066781-20111129-C00013.png)
IE (1) IE41605B1 (US08066781-20111129-C00013.png)
IL (1) IL47796A0 (US08066781-20111129-C00013.png)
LU (1) LU73258A1 (US08066781-20111129-C00013.png)
NL (1) NL7509958A (US08066781-20111129-C00013.png)
NO (1) NO752947L (US08066781-20111129-C00013.png)
SE (1) SE7509532L (US08066781-20111129-C00013.png)
ZA (1) ZA754724B (US08066781-20111129-C00013.png)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4066749A (en) * 1977-01-24 1978-01-03 Merck & Co., Inc. Tetrapeptide analog of TRH
US4215110A (en) * 1978-09-22 1980-07-29 Merck & Co., Inc. Method of treating hypertension
DE2905502C2 (de) * 1979-02-14 1982-07-15 Hoechst Ag, 6000 Frankfurt Verfahren zur Herstellung von LH-RH bzw. LH-RH-Analoga und Pyroglutamyl-N↑i↑m↑-dinitrophenyl-histidin
JPH0684013B2 (ja) * 1985-10-09 1994-10-26 大日本印刷株式会社 成形機における樹脂供給装置

Also Published As

Publication number Publication date
FR2282907A1 (fr) 1976-03-26
IE41605B1 (en) 1980-02-13
ZA754724B (en) 1976-06-30
DK386275A (da) 1976-02-29
NO752947L (US08066781-20111129-C00013.png) 1976-03-02
DD123314A5 (US08066781-20111129-C00013.png) 1976-12-12
NL7509958A (nl) 1976-03-02
GB1478553A (en) 1977-07-06
FI752409A (US08066781-20111129-C00013.png) 1976-02-29
IE41605L (en) 1976-02-28
AU8356775A (en) 1977-02-03
LU73258A1 (US08066781-20111129-C00013.png) 1977-04-15
BE832783A (fr) 1976-02-27
IL47796A0 (en) 1975-10-15
JPS5148662A (US08066781-20111129-C00013.png) 1976-04-26
SE7509532L (sv) 1976-03-01

Similar Documents

Publication Publication Date Title
DE69434136T2 (de) Dolastatin-derivate
EP0939765B1 (de) Glycokonjugate von modifizierten camptothecin-derivaten(a- oder b-ring-verknüpfung)
EP0871653A1 (de) Neue aminosäurederivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende pharmazeutische zusammensetzungen
DE3200812A1 (de) D-phenylalanyl-l-prolyl-l-arginin-aldehyd-sulfat, verfahren zu seiner herstellung und diese verbindung enthaltende arzneimittel
DD243932A5 (de) Verfahren zur herstellung von n,n'-dialkylguanidino-dipeptiden
EP0111266A2 (de) Substituierte Tetrapeptide
DE3508251A1 (de) Dipeptide
EP0934329B1 (de) Glycokonjugate von modifizierten camptothecin-derivaten (20-o-verknüpfung)
DE60025639T2 (de) Substituierte diazepane
EP0981542B1 (de) Glycokonjugate von 20(s)-camptothecin
CH676003A5 (US08066781-20111129-C00013.png)
DE69923460T2 (de) Verfahren zur herstellung von ring-modifizierten zyklischen peptidanalogen
DE2537071A1 (de) Amid
WO1998015571A1 (de) Modifizierte cytostatika
DE2633976A1 (de) Tripeptidderivate, verfahren zu ihrer herstellung sowie diese enthaltende arzneimittel
EP2051992B1 (de) Verfahren zur herstellung von kondensationsprodukten aus n-substituierten glycinderivaten (peptoide) über sequentielle ugi-mehrkomponentenreaktionen
DE2226782A1 (de) Nonapeptide und Verfahren zu deren Herstellung
DE2601820A1 (de) Kathepsin d-inhibitoren
DE3200662C2 (de) Nitrosoharnstoffderivate, Verfahren zu deren Herstellung und Arzneimittel diese enthaltend
DE2063996B2 (de) alpha-Aminoxyhydroxamsäurederivate, Verfahren zur Herstellung derselben und diese enthaltende Arzneimittel
DE1518269B2 (de) Orn hoch 8 -vasopressin und verfahren zu dessen herstellung
DE3688020T2 (de) Peptido-mimetische verbindungen mit hypotensiver wirkung.
EP0069894B1 (de) Optisch aktives Dipeptide, seine pharmazeutisch verträglichen Salze, Verfahren zur Herstellung und diese enthaltende pharmazeutische Präparate
DE3888031T2 (de) Homocyclostatin und Cyclostatin enthaltende Polypeptide als Antihypertensiva.
EP0424670B1 (de) Neue ZNS-aktive Hexapeptide mit antiamnestischer Wirkung

Legal Events

Date Code Title Description
OHJ Non-payment of the annual fee